Listed

U S Physical Therapy Inc

USPHNYSECIK 885978HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$214.1mRevenue, Q2 FY2026, three months to 2026-06-30$214.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 7, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$214.1mRevenue, Q2 FY2026, three months to 2026-06-30$214.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Report this figure+8.5% on a year earlier
  • Gross margin19.6%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $41.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Revenue: $214.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Report this figure−1.5 pts on a year earlier
  • Operating margin10.3%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $21.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Revenue: $214.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Report this figure−2.4 pts on a year earlier
  • Net margin4.6%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $9.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Revenue: $214.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Report this figure−1.7 pts on a year earlier
  • Diluted EPS$0.25Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Report this figure−56.9% on a year earlier
  • Free cash flow$29.0mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $34.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001140361-26-031825. Derived: 6-month figure less the 3-month figure.Capital expenditure: $5.4m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-08-07, accession 0001140361-26-031825. Derived: 6-month figure less the 3-month figure.Report this figure−8.2% on a year earlier

Last eight quarters

Full statements
Revenue$214.1mGross margin 19.6%
Diluted EPS$0.25, Q2 FY2026
Free cash flow$29.0m, Q2 FY2026
U S Physical Therapy Inc, key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m168Revenue, Q3 FY2024, three months to 2024-09-30$168.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001140361-25-041152.Report this figure180Revenue, Q4 FY2024, three months to 2024-12-31$180.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001140361-26-007170. Derived: 12-month figure less the 9-month figure.Report this figure184Revenue, Q1 FY2025, three months to 2025-03-31$183.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001140361-26-020025.Report this figure197Revenue, Q2 FY2025, three months to 2025-06-30$197.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Report this figure197Revenue, Q3 FY2025, three months to 2025-09-30$197.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001140361-25-041152.Report this figure203Revenue, Q4 FY2025, three months to 2025-12-31$202.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001140361-26-007170. Derived: 12-month figure less the 9-month figure.Report this figure198Revenue, Q1 FY2026, three months to 2026-03-31$198.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001140361-26-020025.Report this figure214Revenue, Q2 FY2026, three months to 2026-06-30$214.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Report this figure
Gross margin%17.3%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $29.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-07, accession 0001140361-25-041152.Revenue: $168.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001140361-25-041152.Report this figure18.0%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $32.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-27, accession 0001140361-26-007170. Derived: 12-month figure less the 9-month figure.Revenue: $180.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001140361-26-007170. Derived: 12-month figure less the 9-month figure.Report this figure16.9%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $31.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-08, accession 0001140361-26-020025.Revenue: $183.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001140361-26-020025.Report this figure21.1%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $41.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Revenue: $197.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Report this figure18.7%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $36.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-07, accession 0001140361-25-041152.Revenue: $197.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001140361-25-041152.Report this figure19.8%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $40.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-27, accession 0001140361-26-007170. Derived: 12-month figure less the 9-month figure.Revenue: $202.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001140361-26-007170. Derived: 12-month figure less the 9-month figure.Report this figure16.5%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $32.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-08, accession 0001140361-26-020025.Revenue: $198.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001140361-26-020025.Report this figure19.6%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $41.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Revenue: $214.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Report this figure
Operating margin%7.6%Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: $12.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001140361-25-041152.Revenue: $168.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001140361-25-041152.Report this figure10.9%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $19.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001140361-26-007170. Derived: 12-month figure less the 9-month figure.Revenue: $180.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001140361-26-007170. Derived: 12-month figure less the 9-month figure.Report this figure10.7%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $19.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001140361-26-020025.Revenue: $183.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001140361-26-020025.Report this figure12.6%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $24.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Revenue: $197.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Report this figure12.8%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $25.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001140361-25-041152.Revenue: $197.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001140361-25-041152.Report this figure8.3%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $16.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001140361-26-007170. Derived: 12-month figure less the 9-month figure.Revenue: $202.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001140361-26-007170. Derived: 12-month figure less the 9-month figure.Report this figure6.3%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $12.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001140361-26-020025.Revenue: $198.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001140361-26-020025.Report this figure10.3%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $21.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Revenue: $214.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Report this figure
Net margin%3.9%Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: $6.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001140361-25-041152.Revenue: $168.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001140361-25-041152.Report this figure5.1%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $9.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001140361-26-007170. Derived: 12-month figure less the 9-month figure.Revenue: $180.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001140361-26-007170. Derived: 12-month figure less the 9-month figure.Report this figure5.4%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $9.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-08, accession 0001140361-26-020025.Revenue: $183.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001140361-26-020025.Report this figure6.3%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $12.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Revenue: $197.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Report this figure6.7%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $13.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001140361-25-041152.Revenue: $197.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001140361-25-041152.Report this figure2.0%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $4.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001140361-26-007170. Derived: 12-month figure less the 9-month figure.Revenue: $202.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001140361-26-007170. Derived: 12-month figure less the 9-month figure.Report this figure2.5%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $5.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-08, accession 0001140361-26-020025.Revenue: $198.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001140361-26-020025.Report this figure4.6%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $9.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Revenue: $214.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Report this figure
Diluted EPS$ per share0.39Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001140361-25-041152.Report this figurenot reported (Diluted EPS not reported)0.80Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001140361-26-020025.Report this figure0.58Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.58 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Report this figure0.48Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001140361-25-041152.Report this figurenot reported (Diluted EPS not reported)(0.12)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001140361-26-020025.Report this figure0.25Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001140361-26-031825.Report this figure
Free cash flow$m19.6Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $22.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001140361-25-041152. Derived: 9-month figure less the 6-month figure.Capital expenditure: $2.5m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-11-07, accession 0001140361-25-041152. Derived: 9-month figure less the 6-month figure.Report this figure16.9Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $19.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001140361-26-007170. Derived: 12-month figure less the 9-month figure.Capital expenditure: $2.5m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-02-27, accession 0001140361-26-007170. Derived: 12-month figure less the 9-month figure.Report this figure(7.3)Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: −$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001140361-26-020025.Capital expenditure: $2.6m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-05-08, accession 0001140361-26-020025.Report this figure31.6Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $34.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001140361-26-031825. Derived: 6-month figure less the 3-month figure.Capital expenditure: $3.3m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-08-07, accession 0001140361-26-031825. Derived: 6-month figure less the 3-month figure.Report this figure15.6Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $19.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001140361-25-041152. Derived: 9-month figure less the 6-month figure.Capital expenditure: $4.3m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-11-07, accession 0001140361-25-041152. Derived: 9-month figure less the 6-month figure.Report this figure21.0Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $24.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001140361-26-007170. Derived: 12-month figure less the 9-month figure.Capital expenditure: $3.9m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-02-27, accession 0001140361-26-007170. Derived: 12-month figure less the 9-month figure.Report this figure(1.6)Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001140361-26-020025.Capital expenditure: $5.4m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-05-08, accession 0001140361-26-020025.Report this figure29.0Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $34.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001140361-26-031825. Derived: 6-month figure less the 3-month figure.Capital expenditure: $5.4m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-08-07, accession 0001140361-26-031825. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$781.0mGross margin 19.2%
Diluted EPS$1.42, FY2025
Free cash flow$61.0m, FY2025
U S Physical Therapy Inc, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m495Revenue, FY2021, twelve months to 2021-12-31$495.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-29, accession 0001140361-24-010454.Report this figure553Revenue, FY2022, twelve months to 2022-12-31$553.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-03, accession 0001140361-25-006750.Report this figure605Revenue, FY2023, twelve months to 2023-12-31$604.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001140361-26-007170.Report this figure671Revenue, FY2024, twelve months to 2024-12-31$671.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001140361-26-007170.Report this figure781Revenue, FY2025, twelve months to 2025-12-31$781.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001140361-26-007170.Report this figure
Gross margin%23.7%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $117.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-02-29, accession 0001140361-24-010454.Revenue: $495.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-29, accession 0001140361-24-010454.Report this figure20.3%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $112.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-03, accession 0001140361-25-006750.Revenue: $553.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-03, accession 0001140361-25-006750.Report this figure20.1%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $121.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-27, accession 0001140361-26-007170.Revenue: $604.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001140361-26-007170.Report this figure18.5%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $123.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-27, accession 0001140361-26-007170.Revenue: $671.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001140361-26-007170.Report this figure19.2%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $149.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-27, accession 0001140361-26-007170.Revenue: $781.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001140361-26-007170.Report this figure
Operating margin%14.3%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $70.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-29, accession 0001140361-24-010454.Revenue: $495.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-29, accession 0001140361-24-010454.Report this figure10.3%Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: $56.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-03, accession 0001140361-25-006750.Revenue: $553.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-03, accession 0001140361-25-006750.Report this figure8.4%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $50.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001140361-26-007170.Revenue: $604.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001140361-26-007170.Report this figure9.4%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $63.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001140361-26-007170.Revenue: $671.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001140361-26-007170.Report this figure11.1%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $86.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001140361-26-007170.Revenue: $781.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001140361-26-007170.Report this figure
Net margin%8.2%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $40.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-29, accession 0001140361-24-010454.Revenue: $495.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-29, accession 0001140361-24-010454.Report this figure5.8%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $32.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-03, accession 0001140361-25-006750.Revenue: $553.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-03, accession 0001140361-25-006750.Report this figure4.7%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $28.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001140361-26-007170.Revenue: $604.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001140361-26-007170.Report this figure4.7%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $31.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001140361-26-007170.Revenue: $671.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001140361-26-007170.Report this figure5.1%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $39.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001140361-26-007170.Revenue: $781.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001140361-26-007170.Report this figure
Diluted EPS$ per share2.41Diluted EPS, FY2021, twelve months to 2021-12-31$2.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-29, accession 0001140361-24-010454.Report this figure2.25Diluted EPS, FY2022, twelve months to 2022-12-31$2.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-03, accession 0001140361-25-006750.Report this figure1.28Diluted EPS, FY2023, twelve months to 2023-12-31$1.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-27, accession 0001140361-26-007170.Report this figure1.84Diluted EPS, FY2024, twelve months to 2024-12-31$1.84 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-27, accession 0001140361-26-007170.Report this figure1.42Diluted EPS, FY2025, twelve months to 2025-12-31$1.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-27, accession 0001140361-26-007170.Report this figure
Free cash flow$m68.2Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $76.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-29, accession 0001140361-24-010454.Capital expenditure: $8.2m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2024-02-29, accession 0001140361-24-010454.Report this figure50.3Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $58.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-03, accession 0001140361-25-006750.Capital expenditure: $8.2m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2025-03-03, accession 0001140361-25-006750.Report this figure72.7Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $82.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001140361-26-007170.Capital expenditure: $9.3m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-02-27, accession 0001140361-26-007170.Report this figure65.8Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $74.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001140361-26-007170.Capital expenditure: $9.2m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-02-27, accession 0001140361-26-007170.Report this figure61.0Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $75.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001140361-26-007170.Capital expenditure: $14.1m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-02-27, accession 0001140361-26-007170.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding U S Physical Therapy Inc
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$155.5m2,264,202Added+55,691
Bahl & Gaynor LLC2026-06-30$59.2m861,574Added+16,186
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC2026-06-30$58.1m846,674Reduced−219,182
Copeland Capital Management, LLC2026-06-30$57.8m841,544Added+4,713
STATE STREET CORP2026-06-30$48.6m707,186Added+58,799
MORGAN STANLEY2026-06-30$48.0m698,690Reduced−303,778
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$46.3m674,195Added+10,133
NEUBERGER BERMAN GROUP LLC2026-06-30$41.1m598,894Added+589,645
AMERICAN CENTURY COMPANIES INC2026-06-30$38.4m558,818Added+222,371
SOUTHERNSUN ASSET MANAGEMENT, LLC2026-06-30$36.2m527,765Added+87,861

Recent filings

All 1,279 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

U S Physical Therapy Inc, recent filings
FiledFormWhat it isAccession number
2026-09-2821:08 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0000885978-26-000060
2026-09-2120:17 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000885978-26-000057
2026-08-1420:17 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0000885978-26-000052
2026-08-1220:09 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885978-26-000048
2026-08-1020:12 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885978-26-000045
2026-08-0720:08 ET10-QQuarterly reportPeriod 2026-06-300001140361-26-031825
2026-08-0620:10 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0000885978-26-000042
2026-07-0620:22 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885978-26-000039
2026-05-1920:50 ET8-K5.07 Shareholder vote results0000885978-26-000027
2026-05-1121:12 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885978-26-000024

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 27, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
885978
Tickers
USPH
Exchange
NYSE
SIC code
8000 Services-Health Services
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
NV
Filer category
Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:27 ET. Listed shows no prices and gives no investment advice.